Timely AVF creation in late-referral hemodialysis patients, a two-cohort study: Too late to plan, not too late to act
The Journal of Vascular Access · 2025
DOI: 10.1177/11297298251390107 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Vascular Access, 2025. Verfasst von Elettra Lomeo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Ro…. Hauptthemen laut MEDLINE: Renal Dialysis, Arteriovenous Shunt, Surgical, Kidney Failure, Chronic, Referral and Consultation. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Timely vascular access creation in end-stage kidney disease is critical for optimizing patient outcomes. While early nephrology referral (⩾90 days pre-dialysis) improves access patency and survival, late referral is associated with worse outcomes. Healthcare system structure and demographics may impact vascular access strategies. This study compared late-referral hemodialysis patients from two high-volume hospitals in different healthcare systems, focusing on vascular access and survival.
Methods
This retrospective, two-center study included 463 late-referral hemodialysis patients (mean age 60.4 ± 15.8 years; 63.3% male) initiating dialysis with a tunneled CVC between January 2020 and May 2024 at King’s College Hospital, London ( n = 249) and Policlinico A. Gemelli, Rome ( n = 214). Primary outcome: all-cause mortality. Secondary outcomes: AVF creation, primary and secondary AVF patency, and CRBSI.
Results
AVF recipients had significantly lower mortality than non-AVF patients ( p = 0.002), and a lower bacteremia rate ( p = 0.05) across both Italy and UK cohorts ( p = 0.005 and p = 0.0005, respectively). Time to AVF creation was significantly associated with mortality (OR 1.003; 95% CI 1.000–1.006; p = 0.02). AVF creation was achieved in 42.1% ( n = 195), with primary patency rate of 62.7% at 6 months. Ethnicity ( p = 0.01) and age ( p = 0.0004) influenced AVF type selection. Among non-AVF patients, 26% declined surgery despite eligibility, showing reduced survival ( p = 0.03). CRBSIs occurred in 16% of patients, mostly Gram-positive (70.3%). Relapse rate was higher with CVC removal/replacement than guidewire exchange (19.4% vs 0%; p = 0.01).
Conclusions
Early AVF creation in late-referral hemodialysis patients improves survival and reduces CRBSI risk. Reducing CVC requirement, especially in AVF-eligible patients, is a key strategy to improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Department of Vascular Surgery, King's College Hospital, London, UK.
- Department of Translational Medicine and Surgery, Universita' Cattolica del Sacro Cuore, Rome, Italy.
- Division of Renal Medicine, Ospedale Isola Tiberina-Gemelli Isola, Rome, Italy.
ORCID-Profile: Elettra Lomeo
Zitieren
APA
Lomeo, E., Mangiacapra, R., D'Ascenzo, F. M., Gambhir, R. P. S., Nivedita, M., Grandaliano, G., Valenti, D., & Pesce, F. (2025). Timely AVF creation in late-referral hemodialysis patients, a two-cohort study: Too late to plan, not too late to act. The Journal of Vascular Access. https://doi.org/10.1177/11297298251390107
Vancouver
Lomeo E, Mangiacapra R, D'Ascenzo FM, Gambhir RPS, Nivedita M, Grandaliano G, et al. Timely AVF creation in late-referral hemodialysis patients, a two-cohort study: Too late to plan, not too late to act. The Journal of Vascular Access. 2025. doi:10.1177/11297298251390107
BibTeX
@article{Lomeo2025,
author = {Lomeo, Elettra and Mangiacapra, Roberto and D'Ascenzo, Francesca Maria and Gambhir, Raghvinder Pal Singh and Nivedita, Mitta and Grandaliano, Giuseppe and Valenti, Domenico and Pesce, Francesco},
title = {Timely AVF creation in late-referral hemodialysis patients, a two-cohort study: Too late to plan, not too late to act},
journal = {The Journal of Vascular Access},
year = {2025},
doi = {10.1177/11297298251390107}
}
EUVIMED